TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive DeVita Denies NCI Broke Faith With Communities On CHOP Awards, Says Total Of 30 “Not Absolute” August 15, 1980
TCL Archive Also in This 8-page Issue: In Overhaul of Ethics Rules, NIH Bans Employees From Consulting for and Owning Stock in Biomedical Companies. February 4, 2005
TCL Archive CMS, FDA Developing Process For Concurrent Therapy ApprovalsAACI To Honor Mary-Claire King, Sen. Sherrod Brown October 1, 2010
